# Androgen for Leydig Cell Proliferation

> **NCT01206270** · PHASE2,PHASE3 · COMPLETED · sponsor: **University of Roma La Sapienza** · enrollment: 56 (actual)

## Conditions studied

- Klinefelter Syndrome
- Hypergonadotropic Hypogonadism
- Hypergonadotropic Azospermia
- Hypergonadotropic Cryptozoospermia

## Interventions

- **DRUG:** Testosterone undecanoate
- **DRUG:** Castor Oil

## Key facts

- **NCT ID:** NCT01206270
- **Lead sponsor:** University of Roma La Sapienza
- **Sponsor class:** OTHER
- **Phase:** PHASE2,PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2009-06
- **Primary completion:** 2017-06
- **Final completion:** 2018-06
- **Target enrollment:** 56 (ACTUAL)
- **Last updated:** 2018-09-25


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01206270

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01206270, "Androgen for Leydig Cell Proliferation". Retrieved via AI Analytics 2026-06-08 from https://api.ai-analytics.org/clinical/NCT01206270. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*